These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9199043)

  • 1. [Long-term results of wall stent implantation in benign prostatic hyperplasia and high risk status].
    Goepel M; Senge A; Otto T; Rübben H
    Urologe A; 1997 Mar; 36(2):151-6. PubMed ID: 9199043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Initial experiences with the Memotherm Stent in treatment of benign prostatic hyperplasia].
    Gottfried HW; Schimers HP; Gschwend J; Brändle E; Hautmann R
    Urologe A; 1995 Mar; 34(2):110-8. PubMed ID: 7538708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transurethral thermotherapy for benign prostatic hyperplasia significantly decreases infravesical obstruction: results in 134 patients after 1 year.
    Thalmann GN; Graber SF; Bitton A; Burkhard FC; Gruenig O; Studer UE
    J Urol; 1999 Aug; 162(2):387-93. PubMed ID: 10411044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic UroLume Wallstent for benign prostatic hyperplasia patients at poor operative risk: clinical, uroflowmetric and ultrasonographic patterns.
    Guazzoni G; Bergamaschi F; Montorsi F; Consonni P; Galli L; Matozzo V; Rigatti P
    J Urol; 1993 Nov; 150(5 Pt 2):1641-6; discussion 1646-7. PubMed ID: 7692102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of benign prostatic hyperplasia in high risk patients: long-term experience with the Memotherm stent.
    Gesenberg A; Sintermann R
    J Urol; 1998 Jul; 160(1):72-6. PubMed ID: 9628608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A good alternative to indwelling catheter owing to benign prostate hyperplasia in elderly: Memotherm prostatic stent.
    Bozkurt IH; Yalcinkaya F; Sertcelik MN; Zengin K; Ekici M; Yigitbasi O
    Urology; 2013 Nov; 82(5):1004-7. PubMed ID: 23992964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of prostatic stents in patients with urinary retention who are unfit for surgery. An interim report.
    McLoughlin J; Jager R; Abel PD; el Din A; Adam A; Williams G
    Br J Urol; 1990 Jul; 66(1):66-70. PubMed ID: 1697492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the ASI titanium stent in the management of bladder outflow obstruction due to benign prostatic hyperplasia.
    Kirby RS; Heard SR; Miller P; Eardley I; Holmes S; Vale J; Bryan J; Liu S
    J Urol; 1992 Oct; 148(4):1195-7. PubMed ID: 1383573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia.
    Chiou RK; Chen WS; Akbari A; Foley S; Lynch B; Taylor RJ
    Urology; 1996 Oct; 48(4):589-93. PubMed ID: 8886065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The UroLume stent in the management of benign prostatic hyperplasia.
    Milroy E; Chapple CR
    J Urol; 1993 Nov; 150(5 Pt 2):1630-5. PubMed ID: 7692100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of urodynamics in implantation of prostatic stents].
    Comeri G; Conti G; Cretarola E; Furgoni P; Gianneo E
    Arch Ital Urol Androl; 1995 Feb; 67(1):81-5. PubMed ID: 7538397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-expandable metallic stents in high-risk patients with benign prostatic hyperplasia: long-term follow-up.
    Song HY; Cho KS; Sung KB; Han YM; Kim YG; Kim CS
    Radiology; 1995 Jun; 195(3):655-60. PubMed ID: 7538681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Palliative treatment of symptomatic benign prostatic hyperplasia by permanent urethral stent (Ultraflex, Boston Scientific) in high surgical risk patients].
    Taksin L; Vidart A; Mozer P; Conort P; Richard F; Chartier-Kastler E
    Prog Urol; 2007 Sep; 17(5):954-9. PubMed ID: 17969796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Outcome analysis of the urethral stent (Memotherm®)].
    Sakamoto H; Matsuda A; Arakaki R; Yamada H
    Hinyokika Kiyo; 2012 Jan; 58(1):13-6. PubMed ID: 22343737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia.
    Masood S; Djaladat H; Kouriefs C; Keen M; Palmer JH
    BJU Int; 2004 Dec; 94(9):1271-4. PubMed ID: 15610103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modified prostatic UroLume Wallstent for healthy patients with symptomatic benign prostatic hyperplasia: a European Multicenter Study.
    Guazzoni G; Montorsi F; Coulange C; Milroy E; Pansadoro V; Rubben H; Sarramon JP; Williams G
    Urology; 1994 Sep; 44(3):364-70. PubMed ID: 7521092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of bladder neck obstructions by the Memotherm stent].
    Choquenet C; Kechaou M; Ortega JC
    Prog Urol; 2003 Feb; 13(1):79-84. PubMed ID: 12703358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effects of temporary covered nitinol stent placement in the prostatic urethra: short-term study in the canine model.
    Crisóstomo V; Song HY; Maynar M; Sun F; Soria F; Lima JR; Yoon CJ; Usón-Gargallo J
    Cardiovasc Intervent Radiol; 2007; 30(4):731-7. PubMed ID: 17436035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with the spanner prostatic stent in patients unfit for surgery: an observational study.
    Grimsley SJ; Khan MH; Lennox E; Paterson PH
    J Endourol; 2007 Sep; 21(9):1093-6. PubMed ID: 17941793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction.
    Porpiglia F; Fiori C; Bertolo R; Giordano A; Checcucci E; Garrou D; Cattaneo G; De Luca S; Amparore D
    BJU Int; 2018 Jul; 122(1):106-112. PubMed ID: 29359881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.